ArticleAdvances in therapy2025

ADD2Dia: Real-World Clinical Effectiveness of Adding a Sodium-Glucose Cotransporter 2 Inhibitor to Gliclazide-Based Therapy in Type 2 Diabetes.

Rodrigo O Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.